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Introduction {#sec1}
============

Reactive oxygen species (ROS), including the superoxide anion (O~2~^•−^), hydroxyl radical (OH^•−^), hydrogen peroxide (H~2~O~2~), and singlet oxygen (^1^O~2~), have various functions in cells and tissues. ROS have several sources, including monoamine oxidases, xanthine oxidase, NADPH oxidases (NOXs), and several mitochondrial complexes, which are part of the electron transport chain (ETC) ([@bib3], [@bib4], [@bib6]). In addition, some forms of ROS are changed into others. For example, superoxide dismutase uses O~2~^•−^ as a substrate to generate H~2~O~2~, a more stable, diffusible, and less harmful ROS ([@bib5]). Once generated, H~2~O~2~ modulates the activity of protein phosphatases via oxidizing their catalytic cysteine residues, which can, in turn, enhance kinase-driven signaling pathways ([@bib31]).

Embryonic development is triggered by sperm entry during fertilization, which activates the egg by generating a Ca^2+^ wave and increasing oxygen uptake and ATP synthesis. This increase in oxygen consumption was first noted over 100 years ago in sea urchin eggs ([@bib53]), and it was later found to correlate with increased ROS production ([@bib10]). More recently, it was found that the dual oxidase protein (Udx1) is responsible for the generation of ROS following fertilization in sea urchins ([@bib56]). Notably Wong and colleagues also showed that Udx1 is present throughout early development and that the inhibition of ROS generation using diphenyleneiodonium (DPI) inhibits cell division ([@bib55]). This suggested a role for ROS in the control of the early embryonic cell cycle, but the mechanisms by which ROS regulate the cell cycle and, moreover, whether ROS play similar roles during early vertebrate embryonic development remain unknown.

In early *Xenopus* embryos, the cell cycle is driven by an autonomous oscillator, which is cytokinesis independent ([@bib13], [@bib27]). The cyclin B/cyclin-dependent kinase 1 (Cdk1) complex is a master regulator for entry into mitosis. Accumulating cyclin B levels activate Cdk1, which in turn activates Cdc25C phosphatase, which then dephosphorylates the inhibitory phosphorylated Thr 14 and Tyr 15 in Cdk1, resulting in activation of the cyclin B/Cdk1 complex. This positive feedback loop ensures entry into mitosis. Conversely, Cdk1 also generates a negative feedback loop by activating the anaphase-promoting complex (APC/C^Cdc20^) that promotes degradation of cyclin B, thus ensuring the exit of mitosis. These positive and negative feedback loops are thought to constitute an ultrasensitive bistable circuit to generate the cell cycle oscillator ([@bib9]).

Mitochondria are important organelles that generate ATP in aerobic eukaryotes and participate in other aspects of cellular metabolism and cell signaling. It has been thought that mitochondria produce ROS as a by-product; however, recent studies have shown that mitochondrial ROS (mtROS) can mediate intracellular signaling. For instance, mtROS generated in complex III was shown to be essential in antigen-specific T cell activation *in vivo* ([@bib42]). In fact, there are at least 11 sites in mitochondria that produce ROS ([@bib4], [@bib22]). Although mitochondrial complexes I and III are thought to be the major sources of mtROS, their contributions to overall ROS production appear to differ among species, organs, tissues, and mitochondrial subpopulations. For example, complex III produces most of the ROS generated by heart and lung mitochondria, while complex I is responsible for most of the ROS produced in brain mitochondria *in vitro* ([@bib2], [@bib51], [@bib52]). How or whether mtROS-producing enzymes affect cellular embryonic processes *in vivo*, however, has remained largely unknown.

Using a transgenic *Xenopus* line expressing an H~2~O~2~ indicator, HyPer, we found that fertilization induces a rapid increase in ROS levels *in vivo*. Using this assay, we then explored both the molecular mechanisms that trigger the burst of ROS and how these ROS effect early embryonic development. We show that Ca^2+^ induces ROS production after fertilization and that the major sources of ROS during the early embryonic development are the mitochondria. We then show that mtROS production oscillates with the cell cycle and this oscillation participates in the regulation of the cell cycle in early *Xenopus* embryos, at least partly through ROS-mediated modulation of the cell cycle phosphatase Cdc25C.

Results {#sec2}
=======

Fertilization Induces Increased ROS Levels in *Xenopus* Oocytes {#sec2.1}
---------------------------------------------------------------

We previously showed that *Xenopus* tadpole tail amputation induces sustained ROS production, which is necessary for successful tail regeneration ([@bib20]). For that study, we generated a transgenic *Xenopus laevis* line that ubiquitously expressed the H~2~O~2~ sensor HyPer ([@bib19], [@bib20]). Serendipitously, we found that HyPer was expressed maternally in eggs in the transgenic females. We subsequently found that fertilization induced an 85% increased HyPer ratio (n = 11; 1-cell stage compared to egg, p = 0.001, Wilcoxon matched-pairs signed-rank test), indicating an increased production of ROS that was sustained throughout early development ([Figures 1](#fig1){ref-type="fig"}A and 1B; [Movie S1](#mmc2){ref-type="supplementary-material"}).Figure 1Fertilization and Injury Trigger a Substantial Increase in ROS Levels(A) HyPer ratio images (500/430 nm) showing a ROS production in transgenic embryos expressing HyPer. See also [Movie S1](#mmc2){ref-type="supplementary-material"}.(B) Quantification of HyPer ratio in (A). n = 11; p = 0.001, 1 cell compared to egg, Wilcoxon matched-pairs signed-rank test.(C) Schematic diagram of oocytes experiments. Immature ovarian oocytes were injected with HyPer RNA, matured with 2 μM progesterone, and then pricked by a needle or laser wound activated.(D) HyPer images of immature oocytes expressing HyPer were captured every 20 min after pricking. There is no increase in the HyPer ratio.(E) Quantification of HyPer ratio in (D). n = 33; p = 0.2, 20 min compared to 0 min, paired t test.(F) HyPer images of mature oocytes expressing HyPer were captured every 20 min after pricking. There is an increase in the HyPer ratio.(G) Quantification of HyPer ratio in (F). n = 28; p \< 0.0001, 20 min compared to 0 min, paired t test.(H) SypHer images of mature oocytes expressing Sypher were captured every 20 min after pricking.(I) Quantification of SypHer ratio in (H). n = 27; p \< 0.0001, 20 min compared to 0 min, Wilcoxon matched-pairs signed-rank test.Scale bars, 200 μm (A, D, F, and H). Data are from two independent experiments. Error bars represent mean ± SEM. ^∗∗∗^p ≤ 0.001 and ^∗∗∗∗^p \< 0.0001; ns, not significant. See also [Figure S1](#mmc1){ref-type="supplementary-material"} and [Movie S2](#mmc3){ref-type="supplementary-material"}.

To examine the mechanisms regulating fertilization-induced ROS production in *Xenopus* embryos, we injected non-transgenic, immature oocytes with HyPer mRNAs. We allowed these mRNAs to translate and induced maturation in a subset of these injected oocytes with progesterone ([Figure 1](#fig1){ref-type="fig"}C). While HyPer-expressing immature oocytes failed to activate following pricking and they did not show a change in their ROS levels (n = 33; p = 0.2, 20 min compared to 0 min, paired t test) ([Figures 1](#fig1){ref-type="fig"}D and 1E), HyPer-expressing mature oocytes were immediately activated by pricking, and they showed a dramatic increase in ROS levels (43.5% increase in ratio; n = 28; p \< 0.0001, 20 min compared to 0 min, paired t test), mimicking the increase ROS levels following fertilization ([Figures 1](#fig1){ref-type="fig"}F and 1G). We also found that prick activation of unfertilized eggs obtained from transgenic HyPer-expressing females also resulted in a dramatic increase in ROS production (n = 60; p \< 0.0001, 20 min compared to 0 min, paired t test) ([Figures S1](#mmc1){ref-type="supplementary-material"}A and S1B). Since HyPer has also been shown to be pH sensitive, oocytes were also injected with SypHer RNA, which encodes a pH-sensitive but ROS-insensitive mutant version of HyPer ([@bib34]). While we detected a slight increase of SypHer ratio in prick-activated eggs (3.5% increase in ratio; n = 27; p \< 0.0001, 20 min compared to 0 min, Wilcoxon matched-pairs signed-rank test) ([Figures 1](#fig1){ref-type="fig"}H and 1I), corresponding to a pH increase from 7.37 to 7.42 and consistent with a previous finding ([@bib54]), the change was considerably less than that seen with the ROS-sensitive HyPer version. Therefore, we concluded that the change of HyPer ratio following fertilization is primarily due to an increase in ROS levels rather than a change in pH. Thus, both fertilization and prick activation of mature oocytes and eggs led to a significant increase in ROS production in the activated eggs/zygotes.

To further confirm whether egg activation resulted in elevated ROS levels, we turned to an alternative ROS-detecting assay based on Amplex Red (AR), a compound that can specifically react with H~2~O~2~ in the presence of horseradish peroxidase (HRP) to produce a fluorescent product, resorufin ([Figure S1](#mmc1){ref-type="supplementary-material"}C) ([@bib14]). We injected AR into unfertilized albino eggs with or without HRP, and then we filmed the production of resorufin. We observed strong fluorescence in activated eggs injected with AR and HRP ([Figure S1](#mmc1){ref-type="supplementary-material"}D; [Movie S2](#mmc3){ref-type="supplementary-material"}). Taken together, these data indicate that H~2~O~2~ is generated in mature oocytes and eggs following activation or fertilization and that the ROS levels increased.

ROS Production Is Dependent on the Ca^2+^ Wave after Fertilization {#sec2.2}
------------------------------------------------------------------

Previous studies have shown that sperm entry induces a Ca^2+^ wave, which activates development, cytoskeletal changes, re-entry of the meiotic cell cycle, and subsequent initiation of the mitotic cell cycle ([@bib28]). Oocyte maturation is associated with a rearrangement of Ca^2+^-signaling components, whereby oocytes acquire the ability to propagate a Ca^2+^ wave after fertilization ([@bib8], [@bib21]). Since ROS were not induced in immature oocytes by pricking ([Figures 1](#fig1){ref-type="fig"}D and 1E), we hypothesized that Ca^2+^ signaling may act upstream of ROS production.

To test this hypothesis, first we confirmed that a Ca^2+^ wave was induced by laser wounding (mimicking pricking activation) in mature oocytes expressing R-GECO, a genetically encoded calcium sensor ([Movie S3](#mmc4){ref-type="supplementary-material"}) ([@bib60]). A similar wave was not detected in laser-activated mCherry control immature or mature oocytes, nor in immature R-GECO-injected oocytes ([Movie S3](#mmc4){ref-type="supplementary-material"}). Notably, the Ca^2+^ wave was also induced in mature oocytes by the addition of 10 μM A23187, a Ca^2+^ ionophore, but not following incubation with 0.1% ethanol, the final concentration of solvent used for the ionophore ([Movie S4](#mmc5){ref-type="supplementary-material"}). Importantly, the Ca^2+^ ionophore also induced a 76.7% and 80% increase of HyPer ratio at 40 and 60 min (n = 32--33; p \< 0.0001, compared to control, two-way ANOVA) ([Figures 2](#fig2){ref-type="fig"}A and 2B), suggesting that activation of the Ca^2+^ wave was sufficient to induce the increase in ROS production. To determine if Ca^2+^ influx was necessary for ROS production, we transferred oocytes to calcium-free OR2 medium containing the Ca^2+^ chelator EGTA (100 μM) for 5 min prior to activation. Extracellular Ca^2+^ has been shown to be required for fertilization in *Xenopus* ([@bib57]). In the presence of calcium-free OR2 medium containing EGTA, the Ca^2+^ wave was completely inhibited in laser-activated oocytes ([Movie S5](#mmc6){ref-type="supplementary-material"}), and ROS production was also inhibited 42% and 42.2% at 40 and 60 min after prick activation (n = 32--36; p \< 0.0001, compared to control, two-way ANOVA) ([Figures 2](#fig2){ref-type="fig"}C and 2D).Figure 2ROS Production Is Generated Downstream of Ca^2+^ Signaling(A) HyPer images of control-treated or Ca^2+^ ionophore A23187 (10 μM) -treated mature oocytes injected with HyPer RNA.(B) Quantification of HyPer ratio in (A). n = 32--33; p \< 0.0001, compared to control at 40 and 60 min, two-way ANOVA and Sidak post hoc tests.(C) Oocytes injected with HyPer RNA were matured and cultured in calcium-free OR2 medium with or without EGTA (100 μM), and then HyPer images were taken after prick activation.(D) Quantification of HyPer ratio in (C). n = 32--36; p \< 0.0001, compared to control at 40 and 60 min, two-way ANOVA and Sidak post hoc tests.(E) Oocytes were injected with 20 ng of R-GECO as a control or *inpp5a* and HyPer RNAs, matured, and then imaged after prick activation.(F) Quantification of HyPer ratio in (E). n = 20--25; p \< 0.0001, compared to control at 40 and 60 min, two-way ANOVA and Sidak post hoc tests.Scale bars, 200 μm (A, C, and E). Data are from three independent experiments. Error bars represent mean ± SEM. ^∗∗∗∗^p \< 0.001. See also [Movies S3](#mmc4){ref-type="supplementary-material"}, [S4](#mmc5){ref-type="supplementary-material"}, [S5](#mmc6){ref-type="supplementary-material"}, and [S6](#mmc7){ref-type="supplementary-material"}.

It is known that the Ca^2+^ wave in *Xenopus* zygotes after fertilization is mediated by the IP~3~-signaling pathway ([@bib17], [@bib30]). Consistently, when IP~3~ signaling was inhibited by overexpressing the IP~3~ phosphatase (Inpp5a) in the oocytes, the Ca^2+^ wave was completely abolished ([Movie S6](#mmc7){ref-type="supplementary-material"}) and production of ROS was not detected in prick-activated matured oocytes with 36% and 39.8% reduction in ratio at 40 and 60 min (n = 20--25; p \< 0.0001, compared to control, two-way ANOVA) ([Figures 2](#fig2){ref-type="fig"}E and 2F). These results demonstrate that the fertilization/activation-induced Ca^2+^ wave is both necessary and sufficient to induce ROS production in mature *Xenopus* oocytes and eggs.

ROS Production Downstream of Ca^2+^ Wave Is Mediated by Mitochondria {#sec2.3}
--------------------------------------------------------------------

We next sought to identify the source of ROS production downstream of Ca^2+^ signaling. Cellular ROS are mainly produced by either NOX family enzymes or the ETC in mitochondria. We found that the addition of the NOX inhibitors, 10 μM DPI and 1 mM apocinin, had no effect on ROS production following prick activation in mature oocytes (n = 29--42) ([Figure 3](#fig3){ref-type="fig"}A). In addition, application of the mitochondrial complex I inhibitor rotenone (1 μM), which promotes ROS production in the forward direction and inhibits ROS production via reverse electron transport (RET) at complex I ([@bib26]), did not change HyPer ratios (n = 36; two-way ANOVA) ([Figure 3](#fig3){ref-type="fig"}B), suggesting that complex I is not involved in fertilization-induced ROS production, neither in the forward nor the reverse direction. Addition of high levels of 100 μM DPI, which also inhibits ROS production via RET from complex I ([@bib16]), also did not affect HyPer ratios in activated eggs (data not shown), providing further evidence that the mitochondrial complex I is not the primary source of increased ROS production following egg activation. In contrast, we found that incubation of mature oocytes with 5 mM malonate, which inhibits ROS production from complex II in both the forward and reverse directions ([@bib35]), significantly reduced ROS levels both before (52.8% decrease in ratio) and after activation (68.1%--69.8% decrease in ratio) (n = 45; p \< 0.0001, compared to controls at each time point, two-way ANOVA) ([Figure 3](#fig3){ref-type="fig"}C). A mitochondrial complex III inhibitor, 10 μM antimycin A, and a complex IV inhibitor, 1 mM sodium azide, also attenuated ROS production after prick activation (23.2%--25.9% and 28.7%--31.8%, respectively; n = 46 and 25; p \< 0.0001, compared to control at 40 and 60 min, two-way ANOVA) ([Figures 3](#fig3){ref-type="fig"}D and 3E).Figure 3Mitochondrial Inhibitors Malonate, Antimycin A, and Sodium Azide Impair ROS Production after Activation(A) NOX inhibitors 10 μM DPI or 1 mM apocynin had no effect on HyPer ratio in mature oocytes from HyPer transgenic females after pricking. n = 29--42, two-way ANOVA and Tukey's post hoc tests.(B--F) HyPer ratio on oocytes treated with 1 μM rotenone (n = 36; B), 5 mM malonate (n = 45; p \< 0.0001, compared to control at each time point, two-way ANOVA and Sidak post hoc tests; C), 10 μM antimycin A (n = 46; p \< 0.0001, compared to control at 40 and 60 min, two-way ANOVA and Sidak post hoc tests; D), 1 mM sodium azide (n = 25; p \< 0.0001, compared to control at 40 and 60 min, two-way ANOVA and Sidak post hoc tests; E), and 6 μM oligomycin (n = 42; F).(G) Ca^2+^ wave was measured by fluorescent intensity of R-GECO in laser-activated mature oocytes. Ca^2+^ wave was not affected by any of the mitochondrial inhibitors. Each treatment, n = 6; two independent experiments; two-way ANOVA and Tukey's post hoc tests. See also [Movie S7](#mmc8){ref-type="supplementary-material"}.(H) HyPer ratio on oocytes treated with 2 μM FCCP. n = 36; p \< 0.0001, compared to control at 40 and 60 min, two-way ANOVA and Sidak post hoc tests.Data for (A)--(F) and (H) are from three or four independent experiments. Error bars represent mean ± SEM; ns, not significant; ^∗∗∗∗^p \< 0.0001.

We wondered whether the lack of ROS production following the addition of complex II, III, and IV inhibitors might be due to the depletion of ATP in the mature oocytes. Therefore, we also added the ATP synthase inhibitor oligomycin (6 μM), but this did not affect ROS production in the activated oocytes (n = 42; two-way ANOVA) ([Figure 3](#fig3){ref-type="fig"}F). Furthermore, we found that none of the ETC inhibitors decreased ATP levels in the activated oocytes (n = 3; unpaired t test and Mann-Whitney test) ([Figure S2](#mmc1){ref-type="supplementary-material"}A). To exclude the possibility that the ETC inhibitors affected the Ca^2+^ wave, we tested the ETC inhibitors in R-GECO-expressing oocytes, and we found that none of the inhibitors affected the propagation of the Ca^2+^ wave following laser wounding (n = 6; two-way ANOVA) ([Figure 3](#fig3){ref-type="fig"}G; [Movie S7](#mmc8){ref-type="supplementary-material"}). Finally, we assessed whether the ETC inhibitors affected the intracellular pH of the activated oocytes expressing SypHer, and we found that none of the inhibitors affected the SypHer ratio ([Figures S3](#mmc1){ref-type="supplementary-material"}A--S3E), confirming that the increases in HyPer ratios were due to changes in ROS levels rather than changes in pH levels in the activated oocytes. In summary, these data show that mitochondria are largely responsible for ROS production following egg activation/fertilization and, interestingly, ROS production is primarily generated from complex II of the ETC. Furthermore, the data suggest that mitochondria are not a major source of ATP production following egg activation/fertilization.

To confirm whether the mitochondria are indeed responsible for ROS production after egg activation/fertilization, we employed a mitochondrial targeted HyPer construct (mitoHyPer) to more specifically detect ROS produced in mitochondria ([@bib24]). Immature oocytes were injected with mitoHyPer RNA, and the oocytes were then matured and activated by pricking in the presence of the ETC inhibitors. Although the increases in mitoHyPer ratios were less apparent than those seen with the cytosolic version of HyPer, similar effects of inhibitors on ROS production were observed using mitoHyPer, in that 5 mM malonate (n = 46; 19.8%, 34.6%, and 35.7% at 0, 40, and 60 min), 10 μM antimycin A (n = 42; 14.5% and 16.5% at 40 and 60 min), and 1 mM sodium azide (n = 48; 13.1% and 14.9% at 40 and 60 min) decreased ROS production significantly in activated oocytes (p \< 0.0001, compared to control, two-way ANOVA), while rotenone (n = 46) and oligomycin (n = 40) did not ([Figures S3](#mmc1){ref-type="supplementary-material"}F--S3J). These findings suggest that, while ROS production is primarily generated in the mitochondria, the bulk of the ROS generated within the mitochondria rapidly diffuses into the cytoplasm.

ROS production in mitochondria is known to be regulated by the amplitude of the mitochondrial membrane potential (ΔΨm) ([@bib1]). To examine if ROS production in oocytes depends on the ΔΨm, oocytes expressing HyPer were treated with the mitochondrial uncoupler carbonyl cyanide 3-chlorophenylhydrazone (CCCP). As shown in [Figure 3](#fig3){ref-type="fig"}H, ROS production was significantly reduced by CCCP treatment when compared with controls (39.5% and 39.1% decreases at 30 and 60 min; n = 36; p \< 0.0001, compared to control at 30 and 60 min, two-way ANOVA). Taken together, these data suggest that mitochondria are responsible for the generation of ROS downstream of Ca^2+^ after fertilization/activation.

Ca^2+^ Wave Directly Mediates ROS Production by Mitochondria via MCU {#sec2.4}
--------------------------------------------------------------------

Previous reports have shown that mitochondria uptake calcium from the cytosol via the mitochondrial calcium uniporter (MCU) ([@bib46], [@bib58]). We therefore wondered whether MCU-mediated calcium import was essential for the ROS production following fertilization. To test this hypothesis, we injected oocytes with 0.4 pmol ruthenium red (RuR) (0.4 μM final concentration), an inhibitor of MCU, along with HyPer mRNA. Indeed, oocytes injected with RuR and HyPer mRNA failed to produce ROS after pricking (29.1%--30.5% decrease; n = 23--24; p \< 0.0001, compared to control at each time point, Mann-Whitney test) ([Figures 4](#fig4){ref-type="fig"}A and 4B). To confirm that the inhibition of ROS production in oocytes injected with RuR was specific to MCU, we explored an independent way of inhibiting MCU. It was previously shown that the MCU functions as a tetramer. Furthermore, Raffaello and colleagues ([@bib36]) showed that *MCUb* (also called *Ccdc109b*), encodes an MCU-related protein that acts as an endogenous dominant negative of MCU activity, disrupting the ability for MCU to form a functional tetramer. To exploit this inhibitory property of *mcub*, we injected mRNA encoding *X. tropicalis mcub* RNA with HyPer RNA, and we found that overexpressing *mcub* reduced ROS production in the prick-activated mature oocytes (9.4% and 11.5% decreases; n = 24; p \< 0.01, compared to control at 30 min and p \< 0.001 at 60 min, two-way ANOVA) ([Figures 4](#fig4){ref-type="fig"}C and 4D). Notably, the Ca^2+^ wave after laser activation was not affected by the overexpression of *mcub* ([Movie S8](#mmc9){ref-type="supplementary-material"}). These data show that the increased Ca^2+^ after fertilization enters the mitochondria via the MCU and this results in an increase in mtROS production.Figure 4Ca^2+^ Mediates ROS Production by Mitochondria via MCU(A) HyPer images of oocytes injected with 0.4 pmol RuR (0.4 μM final concentration), MCU inhibitor, and 20 ng HyPer RNA.(B) Quantification of HyPer ratio in (A). ROS production was reduced by MCU inhibition. Two independent experiments; ^∗∗∗∗^p \< 0.0001, compared to control at each time point, Mann-Whitney test. Error bars represent mean ± SEM.(C) HyPer images of oocytes injected with 20 ng of RNA for dominant-negative MCU, *mcub*, and 20 ng HyPer RNA compared to 20 ng HyPer RNA-injected control.(D) Quantification of HyPer ratio in (C). Inhibition of MCU by overexpression of *mcub* impairs ROS production. Error bars represent mean ± SEM.Two independent experiments; ^∗∗^p \< 0.01 and ^∗∗∗^p \< 0.001, compared to control at t30 and t60, two-way ANOVA and Sidak post hoc tests. See also [Movie S8](#mmc9){ref-type="supplementary-material"}. Scale bars, 200 μm (A and D).

mtROS Inhibition Causes Cell Division Arrest during the Early Cleavage Stages of the Embryo {#sec2.5}
-------------------------------------------------------------------------------------------

To elucidate the role of ROS produced by mitochondria in early development, one-cell-stage embryos were treated with various mitochondrial inhibitors toward the end of the first cell cycle. [Figure 5](#fig5){ref-type="fig"}A shows phenotypes of treated embryos observed at the 32-cell stage. Embryos treated with 1 μM rotenone stopped dividing at the 2-cell stage (100%; n = 92). 10 mM malonate and 3 mM sodium azide also caused cell division arrest at the 4- or 8-cell stage (100%; n = 40--58). Embryos treated with 10 μM antimycin A developed normally until the 64-cell stage (97.6%; n = 83); however, their division rates were delayed, and they ultimately underwent embryonic death at the blastula stage (100%; n = 83). Embryos treated with 6 μM oligomycin developed normally up to the blastula stage (n = 88) ([Figure 5](#fig5){ref-type="fig"}A).Figure 5Inhibition of mtROS Induces Cell Division Arrest in *Xenopus* Early Development(A) Embryos were treated at the one-cell stage with 0.1% DMSO (n = 36), 1 μM rotenone (n = 92), 10 mM malonate (n = 40), 3 mM sodium azide (n = 58), 10 μM antimycin A (n = 83), and 6 μM oligomycin (n = 88). Embryos treated with rotenone, malonate, and sodium azide were arrested at the 2- to 8-cell stage. By the blastula stage embryos treated with antimycin A were arrested.(B) 1-cell stage embryos obtained from females expressing HyPer were treated with mitochondrial inhibitors, and HyPer ratio was measured at the 4-cell and 32-cell stages. n = 12--13; ^∗∗∗∗^p \< 0.0001, two-way ANOVA and Tukey's multiple comparisons tests. Error bars represent mean ± SEM.(C) Embryos were treated with 0.1% DMSO or 2 μM CCCP (n = 66).(D) Embryos were injected with water as a control and 50 pmol RuR into one cell at the 2-cell stage. Injection of RuR induced cell-cycle arrest (n = 56).Pictures in (A), (C), and (D) are representative of at least three independent experiments.

To determine whether these phenotypes correlated with a reduction of ROS production, 1-cell-stage embryos obtained from transgenic females expressing HyPer were treated with the various mitochondrial inhibitors to monitor ROS levels. We observed an increase in HyPer ratio in untreated (n = 12) and DMSO (n = 13) control embryos at the 4-cell and 32-cell stages ([Figure 5](#fig5){ref-type="fig"}B). As seen in oocytes, malonate (n = 11) and sodium azide (n = 12) significantly reduced ROS levels 62.9% and 67.7%, respectively, in 4-cell-stage embryos in which cell division was arrested (p \< 0.0001, compared to untreated control, two-way ANOVA). Antimycin A, which caused cell-cycle delay and eventual arrest only at the blastula stage, only slightly reduced ROS production (20.3% at 4-cell stage; n = 12; p \< 0.0001, compared to DMSO control, two-way ANOVA). Oligomycin, an ATP synthase inhibitor, had no effect on either the cell division rates or the ROS levels (n = 11). Although rotenone induced rapid cell division arrest, ROS reduction in these embryos was not observed (n = 12). Given that rotenone has been shown to affect actin dynamics through modification of Rho-GTPase ([@bib40]), which are known to be necessary for cytokinesis ([@bib7]), we interpret this early cell cycle division defect as an inhibition of cytokinesis, rather than inhibiting of the cell cycle oscillator. ATP levels in the embryos treated with the various inhibitors were also measured, and we confirmed that there were no significant reductions in ATP levels in the inhibitor-treated embryos (n = 6; unpaired t test) ([Figure S2](#mmc1){ref-type="supplementary-material"}B), and, thus, the cell-cycle arrest cannot be due to a decrease in ATP levels in the embryos. Consistent with ROS reduction in oocytes treated with CCCP ([Figure 3](#fig3){ref-type="fig"}H), embryos treated with 2 μM CCCP also exhibited cell division arrest at the 4-cell stage (100%; n = 66) ([Figure 5](#fig5){ref-type="fig"}C). Injection of 50 pmol RuR, the MCU inhibitor that caused a reduction of ROS in oocytes ([Figure 4](#fig4){ref-type="fig"}A), also induced cell division defects at the injection site (100%; n = 56) ([Figure 5](#fig5){ref-type="fig"}D). Taken together, these data suggest a strong link between ROS production from mitochondria and progression of the cell-cycle.

We then asked whether the defect of cell division could be rescued by the addition of either H~2~O~2~ or menadione, but neither was able to rescue the cell division arrest caused by malonate or sodium azide (data not shown). This is likely due to the difficulty in reconstituting the correct level of ROS and its dynamics via simple addition of these oxidants. However, given that malonate and sodium azide are reversible inhibitors of mitochondrial complex II and complex IV, respectively, we tested whether cell division and ROS production could be restored after the removal of these inhibitors. Thus, we treated fertilized embryos with the inhibitors, and once they had arrested at the 4-cell stage, we transferred the embryos into fresh medium without the inhibitors. The removal of inhibitor led to the re-initiation of the cell cycle in 48% of embryos treated with malonate and 93% of embryos treated with sodium azide (n = 42--44) ([Figure 6](#fig6){ref-type="fig"}A). Remarkably, most of the rescued embryos then developed to the swimming tadpole stage. Using embryos expressing HyPer, we confirmed that ROS production was restored within 30 min after the removal of inhibitors ([Figure 6](#fig6){ref-type="fig"}B; [Movie S9](#mmc10){ref-type="supplementary-material"}). After treatment of inhibitors (0 min), HyPer ratios were 49.1% in malonate-treated embryos and 33.8% in sodium azide-treated embryos compared to control embryos, but they recovered to 84.9% and 78.9% within 40 min after removal of the inhibitors, respectively (n = 36). Taken together, these data confirm that the cell division defects observed in the embryos treated with malonate and sodium azide were primarily caused by the reduction in ROS levels and that the cell cycle is able to re-initiate once ROS levels are allowed to be restored following inhibitor removal.Figure 6Removal of Inhibitors Restores Cell Division and ROS Production(A) Embryos were treated with inhibitors, 10 mM malonate, 3 mM sodium azide, and 1 μM rotenone, for 40 min until cells stopped dividing (left column), and then they were transferred to a dish containing fresh medium without inhibitors. Embryos transferred after treatment with malonate and azide retrieved cell division and divided to 8- to 16-cell stages (middle), but not in medium with inhibitors (right). Pictures are representative of three independent experiments.(B) Fertilized transgenic embryos expressing HyPer were treated with inhibitors for 40 min and imaged shown as 0 min. Then embryos were transferred to fresh medium without inhibitors, and imaged at 40 and 70 min (n = 34--36; three independent experiments).Error bars represent mean ± SD. See also [Movie S9](#mmc10){ref-type="supplementary-material"}.

Cdc25C-Dependent Cell Cycle Progression Is Regulated by ROS {#sec2.6}
-----------------------------------------------------------

Next we sought to investigate the molecular mechanisms by which ROS may regulate the cell cycle in the early *Xenopus* embryos. Given that H~2~O~2~ is a potent inhibitor of protein tyrosine phosphatases through the reversible oxidation of their catalytic cysteine residues ([@bib18], [@bib38]), we decided to focus on the Cdc25C phosphatase, a key regulator of the cell cycle that, in yeast, has been shown to be redox sensitive ([@bib37], [@bib43], [@bib44]). We therefore endeavored to ask whether Cdc25C might be a target of ROS during the early *Xenopus* mitotic cycles, especially given that *Xenopus* Cdc25C is present at constant levels during early *Xenopus* development ([@bib15]).

Cdc25C activates the cyclin B-Cdk1 complex to induce entry into mitosis by dephosphorylating the inhibitory-phosphorylated Thr 14 and Tyr 15 residues in Cdk-1 ([@bib33]). Cdc25C itself is also regulated by phosphorylation, and it has been shown that there are at least five sites whose phosphorylation correlates with increased phosphatase activity. In contrast, hypophosphorylation of those five sites and phosphorylation on Ser 287 (Ser216 in human) is associated with inactive Cdc25C ([@bib25], [@bib32], [@bib39]). To examine Cdc25C phosphorylation, we performed immunoblots using anti-*Xenopus* Cdc25C antibodies. Embryos treated with the various mitochondrial inhibitors were collected every 15 min and subjected to western blot analysis. Notably, extracts from DMSO control-treated embryos exhibited oscillating hyper- and hypophosphorylation states of Cdc25C, depending on the stage of the cell cycle, correlating with cycling Cdc25C activity ([Figure 7](#fig7){ref-type="fig"}A). Inhibitors that had no effect on ROS production, such as 1 μM rotenone and 6 μM oligomycin, did not change the oscillating state of Cdc25C phosphorylation during the cell cycle, suggesting that these inhibitors do not affect the cell cycle oscillator. In contrast, treatment with 10 mM malonate and 3 mM sodium azide, which cause a reduction in ROS levels, resulted in either a delay or total inhibition in the cycling Cdc25C hyper-/hypophosphorylation oscillations (asterisks in [Figure 7](#fig7){ref-type="fig"}A), suggesting that reduction in ROS levels affected the cycling activation/deactivation pattern of Cdc25 during the cell cycle.Figure 7Inhibition of mtROS Causes Misregulation of Cdc25C Activity Resulting in Mitotic Arrest(A) Immunoblots of *Xenopus* Cdc25C in embryos treated with mitochondrial inhibitors. 10 mM malonate and 3 mM sodium azide, which reduced ROS generation, caused misregulation of Cdc25C (asterisks in the blots).(B) Embryos were treated with inhibitors at the 1-cell stage (90 min after fertilization) and fixed every 10 min for immunohistochemistry. The staining for α-tubulin, Lamin B1, and DNA was used to identify the phase of cell cycle. The numbers in parentheses indicate numbers of embryos examined. A defect in mitotic entry was observed in embryos treated with malonate and sodium azide. Data are from two to three independent experiments.(C) Immunoblots of *Xenopus* cyclin B2 in embryos treated with 10 mM malonate or 3 mM sodium azide. Cyclin B2 degraded before cell-cycle arrest (asterisks in the blots), but its accumulation seemed to be impaired afterward.(D) Immunoblots of *Xenopus* Cdc25C, Cdk-Y15, pan-Cdk, cyclin B2, and α-tubulin in activated eggs treated with 0.1% DMSO, 10 mM malonate, or 3 mM sodium azide at 0, 5, 30, and 80 min after prick activation.(E) Immunoblots detecting human Cdc25C and human Cdc25C-pS216 in activated mature oocytes.Oocytes injected with human Cdc25C WT or C330S/C377S RNA were treated with DMSO or mtROS inhibitors, prick-activated, and extracted at 0, 30, 60, and 90 min.All blots are representative of at least three independent experiments.(F) Plots of measurement of HyPer ratio shown in black (left y axis) and the raw fluorescence intensities at 500 nm of HyPer and YFP embryos shown in the plot as green and yellow lines, respectively (right y axis). Embryos were imaged every 30 s from the beginning of fertilization (0 min) throughout the cleavage stage in [Movie S10](#mmc11){ref-type="supplementary-material"}. Data are representative of at least two independent experiments. See [Movie S11](#mmc12){ref-type="supplementary-material"}.(G) YFP (500 nm)/CFP (430 nm) ratio of embryos expressing HyPer (green) or SypHer (black and pink) obtained by nuclear transplantation of *in vitro*-matured oocytes. Embryos were imaged every 30 s when it started dividing (0 min) throughout the cleavage stage. Data are representative of at least two independent experiments (n = 2--4).

Rotenone inhibited cytokinesis but had no effect on either ROS production or the cell cycle oscillator, as evidenced by the continued cycling of Cdc25C hyper-/hypophosphorylation states ([Figures 5](#fig5){ref-type="fig"}A, 5B, and [7](#fig7){ref-type="fig"}A). It is known that inhibition of cytokinesis does not affect the cell cycle oscillator in early *Xenopus* embryos ([@bib12]). Thus, cytokinesis cannot be used as sole measure of whether the cell cycle oscillator is operational or not in early frog embryos, as evidenced by the lack of cytokinesis in embryos treated with rotenone, yet these embryos still show an oscillating Cdc25 hyper-/hypophosphorylation pattern.

To investigate which phase of the cell cycle was affected by the various treatments, immunohistochemistry was carried out on embryos using antibodies against α-tubulin and Lamin B1, alongside sytox DNA staining to visualize the chromosomes. As shown in [Figure 7](#fig7){ref-type="fig"}B, control embryos proceeded to anaphase of the second cell cycle at 40 min after treatment. On the other hand, embryos showing cell-cycle arrest at 40 min after treatment with malonate or sodium azide had nuclei and microtubules typically seen in prophase. Embryos treated with rotenone proceeded to anaphase similarly to control embryos (data not shown), confirming that the phenotype caused by rotenone is not due to a defect in the nuclear cell cycle. Thus, embryos treated with the mtROS inhibitors (malonate and sodium azide) lost Cdc25C cycling activity and failed to proceed through mitosis, resulting in cell-cycle arrest.

It is known that degradation of cyclin B is critical for mitotic exit. Therefore, we wished to ask whether cyclin B degradation was affected in embryos treated with the mtROS inhibitors. As shown in [Figure 7](#fig7){ref-type="fig"}C, cyclin B degraded at interphase in control embryos. In embryos treated with the mtROS inhibitors, cyclin B degradation was observed as expected in interphase before cell-cycle arrest at the 4-cell stage in azide and at the 8-cell stage in malonate (asterisks in [Figure 7](#fig7){ref-type="fig"}C). However, after cell-cycle arrest, the accumulation of cyclin B required for mitotic re-entry was not detected. This observation indicates that the failure of mitotic arrest caused by mtROS inhibitors is not due to disregulation of cyclin B degradation, although we did find a disregulation in cyclin B re-accumulation in the subsequent cell cycle.

To determine whether mtROS have an impact on Cdc25C phosphatase activity, the phosphorylation state of Tyr 15 of Cdk1, a direct target of Cdc25C, was examined by immunoblot using an anti-Cdk1-Y15 antibody ([@bib50]). To examine how Cdc25C activity is regulated by mtROS, unfertilized eggs were activated by pricking and collected at different time points. As shown in [Figure 7](#fig7){ref-type="fig"}D, endogenous Cdc25C was hyperphosphorylated before activation (t0), and it was enzymatically active since phosphorylation of Cdk1 at Tyr 15 was not detected. At 30 min after prick activation (t30), control mature oocytes exhibited hypophosphorylation, and, coincident with this, its specific substrate (Cdk1-Tyr15) was phosphorylated, suggesting diminished Cdc25C activity ([Figure 7](#fig7){ref-type="fig"}D). However, under the condition where mtROS were inhibited by either malonate or sodium azide, Cdc25C remained enzymatically active after 30 min, as suggested by undetectable Cdk1-Tyr 15 phosphorylation ([Figure 7](#fig7){ref-type="fig"}D). Intriguingly, sodium azide, which is the more potent inhibitor of the cell cycle, displayed continued Cdc25 activity and/or Wee1 inactivity, even after 80 min when control oocytes showed recovery of Cdk1-Tyr15 phosphorylation. In addition, activated oocytes treated with malonate, which delays progression through the cell cycle prior to complete inhibition, exhibited an intermediate level Cdk-Tyr15 phosphorylation, suggesting continued Cdc25 activity after 30 min and/or diminished Wee1 activity, relative to the control oocytes ([Figure 7](#fig7){ref-type="fig"}D). Consistent with our findings in embryos ([Figure 7](#fig7){ref-type="fig"}C), cyclin B degradation still occurred normally by t30 in the activated oocytes treated with malonate or sodium azide, but both inhibitors either delayed (malonate) or inhibited (sodium azide) the recovery of cyclin B levels at 80 min (t80) ([Figure 7](#fig7){ref-type="fig"}D). These data indicate that mtROS are involved in the rapid downregulation of Cdc25C activity at the meiotic exit and, in its absence, Cdc25 activity remains high, especially under continual sodium azide treatment.

Cdc25 has been proposed to be regulated by oxidation of the conserved cysteines in the catalytic domain ([@bib37], [@bib43]). To test whether these cysteine residues are involved in the dynamic post-translational regulation of Cdc25C, we utilized the oocyte system to overexpress human Cdc25C containing mutations in the two critical redox-sensitive cysteine residues, C330S and C377S ([@bib41]). Monitoring the human Cdc25C protein also allowed us to assess the dynamics of the phosphorylation state of serine 216, which is inhibitory to its subcellular localization and activity ([@bib47]), as the available anti-Cdc25C (phospho S216) antibody reacts with the human isoform, but not the endogenous *Xenopus* Cdc25 protein at its homologous position at serine 287. Activation of Cdc25C induced by progesterone has been shown to be important for oocyte maturation, and overexpression of Cdc25C induces precocious oocyte maturation in *Xenopus* ([@bib11], [@bib33]). Indeed, we noticed that injection of 5 ng wild-type human Cdc25C RNA induced oocyte maturation without progesterone treatment. Since overexpression of mutant human Cdc25C RNA did not inhibit maturation induced by progesterone, and co-injection of human Cdc25C mutant RNA (1--10 ng) with 5 ng wild-type human Cdc25C RNA did not prevent the precocious maturation by the wild-type Cdc25C, it is unlikely that mutant human Cdc25C acts as a dominant negative. We also confirmed that injection of 500 pg mutant RNA had no effect on embryonic development when it was injected at the 1-cell stage (data not shown). For our experiments, we injected 100 pg of wild-type or mutant human Cdc25C RNAs, which did not induce precocious oocyte maturation and did not disrupt maturation induced by progesterone.

We found that both the wild-type (WT) and the C330S/C377S mutant form of human Cdc25 were hyperphoshorylated in the oocytes prior to prick activation. Furthermore, at t0, no detectable phosphorylation at S216 was observed, suggesting that both the WT and mutant forms had the post-translational hallmarks of active Cdc25 (t0 in [Figure 7](#fig7){ref-type="fig"}E, top DMSO control-treated oocytes). At 30 min after prick activation, both the WT and mutant Cdc25 became fully hypophosphorylated, and both forms contained the inactive S216 phosphorylation state (t30 in [Figure 7](#fig7){ref-type="fig"}E, top DMSO control-treated oocytes). Inhibiting mtROS production following oocyte activation by treating them with malonate resulted in the retention of the hyperphosphorylated WT and mutant forms of Cdc25, as well as the sustained lack of phosphorylation of the inhibitory S216 site, suggesting that inhibition of mtROS via malonate resulted in the retention of post-translational modification of Cdc25 associated with a sustained active state ([Figure 7](#fig7){ref-type="fig"}E, middle malonate-treated oocytes). Furthermore, inhibiting mtROS with sodium azide resulted in a delay in the change from hyper- to hyperphosphorylation state of the WT and mutant forms of Cdc25, such that, at t30, there still remained significant amounts of hyperphosphorylated Cdc25, while DMSO-treated oocytes at t30 had no hyperphosphorylated Cdc25 left, and, interestingly, the mutant form was more delayed in acquiring its inhibitory phosphorylation at S216 than the WT form at t30, suggesting that the rate of deactivation in the mutant was slower when Cdc25 lacked the two ROS-sensitive cysteines ([Figure 7](#fig7){ref-type="fig"}E, bottom sodium azide-treated oocytes). These data suggest that mtROS facilitate the inactivation of Cdc25C through its ROS-sensitive cysteine residues.

ROS Oscillate with the Cell Cycle {#sec2.7}
---------------------------------

Having seen that inhibiting ROS production leads to cell-cycle arrest, as well as the loss of the oscillatory phosphorylation and activity states of Cdc25, we hypothesized that ROS levels might also oscillate during the early *Xenopus* embryo, coincident with the cell cycle. Thus, we returned to HyPer imaging of early embryos and began imaging the embryos in greater detail. We found that ROS levels do fluctuate during the cell cycle ([Figure 7](#fig7){ref-type="fig"}F, black line; [Movies S10](#mmc11){ref-type="supplementary-material"} and [S11](#mmc12){ref-type="supplementary-material"}). We also imaged embryos expressing YFP maternally, and fluorescence intensity at 500 nm was measured every 30 s. As shown in [Figure 7](#fig7){ref-type="fig"}F, while HyPer signal (green line) showed oscillatory fluctuations, YFP (yellow line) did not. To eliminate the possibility that an oscillating change in pH may be responsible for the oscillating HyPer pattern, we generated embryos expressing SypHer. While we observed a clear oscillation pattern in HyPer ratios (green line), we failed to observe oscillating SypHer ratios in the embryos (pink and black lines) ([Figure 7](#fig7){ref-type="fig"}G). These results strongly suggest that ROS levels oscillate through the cell cycle, thus explaining why the cell-cycle arrest could not be simply rescued by the addition of H~2~O~2~ or menadione, as these treatments would not have reconstituted the oscillating patterns of ROS necessary for restoring the cell cycle.

Discussion {#sec3}
==========

We have previously shown that tail amputation in *Xenopus* tadpoles induces a sustained increase in ROS levels throughout tail regeneration and these increased levels are required for tail regeneration ([@bib20]). Intriguingly, we show here that fertilization also triggers increased ROS levels, which are sustained, yet oscillating with the cell cycle, during early embryonic development. Given that the events triggered by fertilization can be mimicked by prick activation or laser wounding, one might consider fertilization as a sort of injury, which triggers sustained ROS production and cell cycle progression and development, in the same way that tail amputation triggers sustained ROS production, which is essential for cell proliferation, growth factor signaling, and, ultimately, appendage regeneration. Indeed, we also know that both tissue injury and fertilization induce a rapid Ca^2+^ wave ([@bib45]), which, in the context of fertilization, is necessary and sufficient for ROS production via the Ca^2+^ uniporter MCU. Intriguingly, however, we find that the source of ROS production is different in both scenarios. While NADPH oxidase activity is the primary source of ROS production following tail amputation ([@bib20]), ROS production following fertilization or egg activation is primarily dependent on the mitochondrial ETC, more specifically complexes II, III, and IV. Although we have used DPI as a potent NADPH oxidase inhibitor, DPI has also been shown to inhibit the FMN coenzyme of complex I ([@bib23]) and ROS production from complex I via RET ([@bib16]). In our studies, neither high concentration of DPI (100 μM) nor rotenone affected ROS production in oocytes or embryos, indicating that complex I is not responsible for ROS production in early embryos. Thus, we find that complex I, the site traditionally viewed as the major source of mtROS production ([@bib22], [@bib26]), is not involved in ROS production in the early frog embryos, suggesting the mitochondria in early embryos do not behave in a canonical manner. This is further supported by our finding that inhibiting the mitochondrial ETC does not decrease ATP levels in the early embryos. It is thus fascinating to speculate whether mitochondria in early embryos are primarily used as signaling organelles, via ROS production, rather than ATP-producing organelles. The use of mitochondria-targeted antioxidants may provide further information for understanding the mechanism of ROS production by mitochondria during early embryogenesis.

Our previous study on the role of ROS production during appendage regeneration showed that inhibiting ROS production resulted in a significant decrease in proliferation following tail amputation ([@bib20]). However, in that study, we also found that both Wnt and FGF signaling were attenuated when ROS production was inhibited. Given that cell proliferation is often controlled via growth factor signaling, it was not clear from that study whether the cell proliferation defect was a consequence of attenuated growth signaling or whether ROS levels affected growth factor signaling and cell proliferation independently. This study provides evidence that ROS are capable of impacting cell proliferation independently from their effects on growth factors signaling. This is because the early cell cycle progression in frog embryos is not dependent on growth factor signaling. Indeed, growth factor signaling does not play a role in development until the mid-blastula stage, when zygotic transcription is initiated ([@bib29], [@bib59]), yet we find that attenuating ROS levels affects the cell cycle at the cleavage stages. Intriguingly, after a burst of ROS production following fertilization, we find that ROS levels then oscillate with the cell cycle and that the elevated, oscillating ROS levels are necessary for the cell cycle to progress. We were unable to rescue cell-cycle arrest caused by mtROS inhibitors by adding H~2~O~2~ or menadione. This is likely due to the fact that ROS levels oscillate during the cell cycle, an aspect that was not reproduced adequately in the attempted rescue experiments.

The control of the cell cycle in *Xenopus* early embryos involves positive and negative feedback loops, which constitute a bistable mitotic trigger ([@bib48]). For generation of robust bistability, ultrasensitivity of Cdc25C has been suggested ([@bib49]). In this study, we have shown that the conserved cysteine residues in Cdc25C help mediate a quick inactivation of Cdc25C, suggesting that ROS may supply Cdc25C with the necessary ultrasensitivity for robustness suggested by Trunnell and colleagues. Although here we have focused on the redox-sensitive Cdc25C, future studies will strive to identify other redox-sensitive proteins and how they utilize the fertilization-induced, oscillatory ROS production to ensure successful progression through early embryonic development.

Experimental Procedures {#sec4}
=======================

Further details and an outline of resources used in this work can be found in the [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

Experimental Animals {#sec4.1}
--------------------

All experiments involving animals were approved by the local ethics committee and the Home Office. Unfertilized oocytes were obtained from *X. laevis* WT females by injecting with 250 units of human chorionic gonadotropin (HCG). Embryos were obtained from *in vitro* fertilization. Ovaries were isolated from females after they had been humanely sacrificed.

Manipulation of *Xenopus* Oocytes and Embryos {#sec4.2}
---------------------------------------------

RNA synthesis using SP6 Message Machine was carried out following the manufacturer's protocol (Life Technologies). Stage VI oocytes were isolated manually from ovaries of pregnant mare serum gonadotropin (PMSG)-primed female frogs, injected with 20 ng HyPer or SypHer RNA, and cultured in OR2 medium at 16°C for 24 hr. Then progesterone was added to the medium at a final concentration of 2 μM for 16 hr at 16°C. The 20 ng HyPer RNA was co-injected with 20 ng *inpp5a* phosphatase RNA or 20 ng *mcub* RNA, cultured, and matured as above. To inhibit MCU, oocytes were injected with 0.4 pmol RuR (0.4 μM final concentration) and 20 ng HyPer RNA, and they were cultured in OR2 medium at 16°C for 24 hr before *in vitro* maturation. Embryos were injected with 10 nL 5 mM RuR into one blastomere at the 2-cell stage and cultured at 22°C in 0.1X Marc's modified ringers (MMR).

Oocytes injected with 100 pg human Cdc25c RNA for WT or cysteine mutants were treated with progesterone immediately after injections. Matured oocytes were identified by the presence of a white spot at the animal pole, associated with germinal vesicle breakdown. Oocytes were incubated with inhibitors for 20 min before prick activation.

Statistical Analysis {#sec4.3}
--------------------

Statistical analyses were performed with Prism (GraphPad). Data were first checked for variance, and the appropriate statistical tests showed in each figure legend were used to generate p values; p values \< 0.05 were considered significant as follows: ^∗^ p \< 0.05, ^∗∗^ p \< 0.01, ^∗∗∗^ p \< 0.001, and ^∗∗∗∗^ p \< 0.0001.

Supplemental Information {#app2}
========================

Document S1. Supplemental Experimental Procedures and Figures S1--S3Movie S1. Time-Lapse Movie Showing ROS Production from Fertilization to the Blastula Stages in Transgenic Embryo Expressing HyPer, Related to Figure 1Signal was obtained using excitation filters of 490/20 nm (left) and 402/15 nm (middle) with an emission filter of BP525/36. The HyPer ratio was calculated using ImageJ (right).Movie S2. ROS Detection Using AR, Related to Figure 1Albino oocytes were injected with AR only (left) and AR with HRP, and time lapse movies were taken every 1 min after injection using Leica M205FA with DSR filter (pseudo color).Movie S3. Detection of Ca^2+^ Wave with R-GECO after Laser Activation, Related to Figure 2Image of immature (left) and mature (mature) oocytes injected with mCherry (3 s of movie) or R-GECO (3 s of movie). Ca^2+^ wave was observed in the R-GECO movie, but only in the mature oocyte (right).Movie S4. Ca2+ Wave Is Induced by the Addition of Ca2+ Ionophore A23187 in Mature Oocyte (Right), Related to Figure 2Ethanol alone control does not induce Ca^2+^ wave (left).Movie S5. Ca^2+^ Wave Induced by Laser in Mature Oocyte Is Disrupted in Calcium-Free OR2 Medium with EGTA (100 μM), Related to Figure 2Movie S6. Overexpression of *inpp5a* in Oocyte Impairs Ca^2+^ Wave, Related to Figure 2Movie S7. Mitochondrial Inhibitors Do Not Disrupt Ca^2+^ Wave, Related to Figure 3Movie S8. Overexpression of *mcub* RNA Does Not Inhibit Ca^2+^ Wave, Related to Figure 4Movie S9. Removal of Inhibitors, 10 mM Malonate and 3 mM Sodium Azide, Restores the ROS Production in HyPer Transgenic Embryos, Related to Figure 6Time lapse movies were taken every 30 s after 4-cell arrested embryos were transferred to medium without inhibitors.Movie S10. Oscillation of ROS along with Cell Division, Related to Figure 7FSperm solution was added to unfertilized oocyte expressing HyPer, and imaged every 30 s for 5 hr. Images were processed without smooth using ImageJ and Brightness/Contrast was set between 1.2 and 1.6.Movie S11. Another Example of Oscillation of ROS in Embryo Expressing HyPer, Related to Figure 7FA dividing embryo after fertilization was imaged every 30 s for 5 hr with 1,000 ms exposure for YFP500 and 500 ms for CFP430. Images were processed without smooth and Brightness/Contrast was set between 2.9 and 3.8.Document S2. Article plus Supplemental Information
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